In recent years it has become evident that the vitreous must play a ro
le in various aspects of diabetic retinopathy. The exact role of the v
itreous is however in many aspects still ill defined. There are struct
ural changes of the vitreous, as for instance vitreous liquefaction an
d posterior vitreous detachment, that are associated with the occurren
ce and earlier onset of diabetic retinopathy. Further there are angiog
enic and angioinhibitory factors in the vitreous which influence neova
scularisation by means of endothelial cell proliferation. Photocoagula
tion of the retina can cause structual changes (posterior vitreal deta
chment) and histological changes (increased hyalocytes activity) which
can protect against the progression of proliferative diabetic retinop
athy. The role of vitrectomy in protecting against proliferative diabe
tic retinopathy is generally concerned to be related to the removal of
the vitreal scaffold. But vitrectomy can also induce changes in the o
xygenation of the eye. If complete detachment of the posterior vitreou
s can be achieved it might be possible to further slow the progression
of diabetic retinopathy. Conclusions It is possible that in the futur
e manipulation of the vitreous by means of enzymes and lasers can play
a role in the treatment and prevention of diabetic retinopathy.